NYSE:UNH - UnitedHealth Group Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$253.02 -1.85 (-0.73 %)
(As of 06/20/2018 05:15 AM ET)
Previous Close$254.87
Today's Range$251.16 - $253.30
52-Week Range$182.22 - $256.73
Volume2.37 million shs
Average Volume3.49 million shs
Market Capitalization$245.99 billion
P/E Ratio25.13
Dividend Yield1.41%
Beta0.74
UnitedHealth Group logoUnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

Receive UNH News and Ratings via Email

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:UNH
CUSIP91324P10
Phone952-936-1300

Debt

Debt-to-Equity Ratio0.56
Current Ratio0.71
Quick Ratio0.71

Price-To-Earnings

Trailing P/E Ratio25.13
Forward P/E Ratio20.05
P/E Growth1.48

Sales & Book Value

Annual Sales$201.16 billion
Price / Sales1.21
Cash Flow$12.4090 per share
Price / Cash20.39
Book Value$51.42 per share
Price / Book4.92

Profitability

EPS (Most Recent Fiscal Year)$10.07
Net Income$10.56 billion
Net Margins5.41%
Return on Equity22.06%
Return on Assets7.41%

Miscellaneous

Employees260,000
Outstanding Shares960,980,000

UnitedHealth Group (NYSE:UNH) Frequently Asked Questions

What is UnitedHealth Group's stock symbol?

UnitedHealth Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "UNH."

How often does UnitedHealth Group pay dividends? What is the dividend yield for UnitedHealth Group?

UnitedHealth Group announced a quarterly dividend on Wednesday, June 6th. Shareholders of record on Monday, June 18th will be given a dividend of $0.90 per share on Tuesday, June 26th. This represents a $3.60 annualized dividend and a yield of 1.42%. The ex-dividend date is Friday, June 15th. This is a boost from UnitedHealth Group's previous quarterly dividend of $0.75. View UnitedHealth Group's Dividend History.

How will UnitedHealth Group's stock buyback program work?

UnitedHealth Group declared that its Board of Directors has authorized a share buyback plan on Wednesday, June 6th 2018, which permits the company to repurchase 100,000,000 shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its stock is undervalued.

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Inc (NYSE:UNH) posted its earnings results on Tuesday, April, 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.13. The healthcare conglomerate earned $55.19 billion during the quarter, compared to the consensus estimate of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The business's revenue was up 13.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.37 earnings per share. View UnitedHealth Group's Earnings History.

When is UnitedHealth Group's next earnings date?

UnitedHealth Group is scheduled to release their next quarterly earnings announcement on Tuesday, July, 17th 2018. View Earnings Estimates for UnitedHealth Group.

What guidance has UnitedHealth Group issued on next quarter's earnings?

UnitedHealth Group updated its FY18 earnings guidance on Tuesday, April, 17th. The company provided earnings per share guidance of $12.40-12.65 for the period, compared to the Thomson Reuters consensus estimate of $12.54.

What price target have analysts set for UNH?

25 brokers have issued twelve-month target prices for UnitedHealth Group's shares. Their forecasts range from $185.00 to $300.00. On average, they anticipate UnitedHealth Group's stock price to reach $258.8333 in the next twelve months. View Analyst Ratings for UnitedHealth Group.

Who are some of UnitedHealth Group's key competitors?

Who are UnitedHealth Group's key executives?

UnitedHealth Group's management team includes the folowing people:
  • Mr. Stephen J. Hemsley, Exec. Chairman (Age 65)
  • Mr. David Scott Wichmann, CEO & Director (Age 55)
  • Mr. John F. Rex, Exec. VP & CFO (Age 56)
  • Ms. Marianne D. Short, Exec. VP & Chief Legal Officer (Age 66)
  • Mr. Larry Chester Renfro, Vice Chairman & CEO of Optum (Age 64)

Has UnitedHealth Group been receiving favorable news coverage?

News headlines about UNH stock have been trending somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UnitedHealth Group earned a news impact score of 0.24 on Accern's scale. They also gave media coverage about the healthcare conglomerate an impact score of 46.50 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are UnitedHealth Group's major shareholders?

UnitedHealth Group's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.02%), Northern Trust Corp (1.20%), Summit Trail Advisors LLC (0.65%), American Century Companies Inc. (0.53%), Legal & General Group Plc (0.48%) and Schwab Charles Investment Management Inc. (0.41%). Company insiders that own UnitedHealth Group stock include D Ellen Wilson, Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Steven H Nelson, Thomas E Roos and William C Ballard Jr. View Institutional Ownership Trends for UnitedHealth Group.

Which major investors are selling UnitedHealth Group stock?

UNH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Boston Partners, Massachusetts Financial Services Co. MA, Swiss National Bank, Legal & General Group Plc, CI Investments Inc., Prudential Financial Inc. and Northern Trust Corp. Company insiders that have sold UnitedHealth Group company stock in the last year include Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Steven H Nelson, Thomas E Roos and William C Ballard Jr. View Insider Buying and Selling for UnitedHealth Group.

Which major investors are buying UnitedHealth Group stock?

UNH stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Westfield Capital Management Co. LP, OppenheimerFunds Inc., Ceredex Value Advisors LLC, Mackay Shields LLC, CIBC World Markets Inc., Natixis and Winslow Capital Management LLC. View Insider Buying and Selling for UnitedHealth Group.

How do I buy shares of UnitedHealth Group?

Shares of UNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is UnitedHealth Group's stock price today?

One share of UNH stock can currently be purchased for approximately $253.02.

How big of a company is UnitedHealth Group?

UnitedHealth Group has a market capitalization of $245.99 billion and generates $201.16 billion in revenue each year. The healthcare conglomerate earns $10.56 billion in net income (profit) each year or $10.07 on an earnings per share basis. UnitedHealth Group employs 260,000 workers across the globe.

How can I contact UnitedHealth Group?

UnitedHealth Group's mailing address is 9900 BREN ROAD EAST, MINNEAPOLIS MN, 55343. The healthcare conglomerate can be reached via phone at 952-936-1300 or via email at [email protected]


MarketBeat Community Rating for UnitedHealth Group (UNH)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  1,130 (Vote Outperform)
Underperform Votes:  408 (Vote Underperform)
Total Votes:  1,538
MarketBeat's community ratings are surveys of what our community members think about UnitedHealth Group and other stocks. Vote "Outperform" if you believe UNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.